Cargando…

Prediction model of gonadotropin starting dose and its clinical application in controlled ovarian stimulation

BACKGROUND: Selecting an appropriate and personalized Gn starting dose (GSD) is an essential procedure for determining the quality and quantity of oocytes in the controlled ovarian stimulation (COS) process of the in-vitro fertilization (IVF) treatment cycle. The current approach for determining the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hua, Liang, Zhe, Yang, Jing, Yang, Fujin, Shen, Jiao, Chen, Liu, Liu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635211/ https://www.ncbi.nlm.nih.gov/pubmed/36333671 http://dx.doi.org/10.1186/s12884-022-05152-6

Ejemplares similares

Machine Learning-Based Modeling of Ovarian Response and the Quantitative Evaluation of Comprehensive Impact Features
por: Liu, Liu, et al.
Publicado: (2022)

Original delayed-start ovarian stimulation protocol with a gonadotropin-releasing hormone antagonist, medroxyprogesterone acetate, and high-dose gonadotropin for poor responders and patients with poor-quality embryos
por: Takeuchi, Kazuhiro, et al.
Publicado: (2023)

The gonadotropins starting dose calculator, which can be adjusted the target number of oocytes and stimulation duration days to achieve individualized controlled ovarian stimulation in Japanese patients
por: Kobanawa, Masato
Publicado: (2023)

Gonadotropin levels at the start of ovarian stimulation predict normal fertilization after hCG re‐trigger in GnRH antagonist cycles
por: Kitasaka, Hiroya, et al.
Publicado: (2020)

Nomogram to predict FSH starting dose in poor ovarian response women in progestin primed ovarian stimulation protocol
por: Wu, Shuxie, et al.
Publicado: (2023)

Random Start Ovarian Stimulation
por: Kumar, Pratap, et al.
Publicado: (2022)

A Novel Nomogram for Individualized Gonadotropin Starting Dose in GnRH Antagonist Protocol
por: Li, Yubin, et al.
Publicado: (2021)

Human steroidogenesis: implications for controlled ovarian stimulation with exogenous gonadotropins
por: Andersen, Claus Y, et al.
Publicado: (2014)

Gonadotropin releasing hormone analogs as part of controlled ovarian stimulation
por: Fleming, Richard
Publicado: (2022)

Type and dose of gonadotropins in poor ovarian responders: does it matter?
por: Boudry, Liese, et al.
Publicado: (2021)

Understanding Ovarian Hypo-Response to Exogenous Gonadotropin in Ovarian Stimulation and Its New Proposed Marker—The Follicle-To-Oocyte (FOI) Index
por: Alviggi, Carlo, et al.
Publicado: (2018)

Effect of Genetic Variants of Gonadotropins and Their Receptors on Ovarian Stimulation Outcomes: A Delphi Consensus
por: Conforti, Alessandro, et al.
Publicado: (2022)

The İmpact of Gonadotropin Type on Controlled Ovarian Stimulation and İntrauterine İnsemination Cycle Outcomes
por: Cicek, Ozge Senem Yucel, et al.
Publicado: (2022)

Low-dose human chorionic gonadotropin supplementation initiated at the onset of ovarian stimulation can improve oocyte quality without impairing endometrial receptivity: Case series
por: Lin, Huizhen, et al.
Publicado: (2022)

Adrenocorticotropic Hormone Suppresses Gonadotropin-Stimulated Estradiol Release from Zebrafish Ovarian Follicles
por: Alsop, Derek, et al.
Publicado: (2009)

Effects of human menopausal gonadotropin on zona pellucida and pregnancy outcomes of ovarian stimulation protocols
por: He, Bing, et al.
Publicado: (2015)

Comparison of different starting gonadotropin doses (50, 75 and 100 IU daily) for ovulation induction combined with intrauterine insemination
por: Streda, Robert, et al.
Publicado: (2012)

Efficacy of Random-start Controlled Ovarian Stimulation in Cancer Patients
por: Kim, Jee Hyun, et al.
Publicado: (2015)

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
por: Shim, Yoo Jin, et al.
Publicado: (2018)

Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?
por: Haas, Jigal, et al.
Publicado: (2017)

Urinary Versus Recombinant Gonadotropins for Ovarian Stimulation in Women Undergoing Treatment with Assisted Reproductive Technology
por: Patki, Ameet, et al.
Publicado: (2018)

Past, Present, and Future of Gonadotropin Use in Controlled Ovarian Stimulation During Assisted Reproductive Techniques
por: Prodromidou, Anastasia, et al.
Publicado: (2021)

Gonadotropin versus Follicle-Stimulating Hormone for Ovarian Response in Patients Undergoing in vitro Fertilization: A Retrospective Cohort Comparison
por: Ji, Zhisong, et al.
Publicado: (2019)

Gonadotropin-releasing Hormone Stimulation Test for Precocious Puberty
por: Kim, Han Kyul, et al.
Publicado: (2011)

Ovarian stimulation with human and recombinant gonadotropin – comparison of in vitro fertilization efficiency with use of time-lapse monitoring
por: Wdowiak, Artur, et al.
Publicado: (2015)

A Study of Controlled Ovarian Stimulation with Clomiphene Citrate or Letrozole in Combination with Gonadotropins and IUI in Unexplained Infertility
por: Hembram, Madhusmita, et al.
Publicado: (2017)

Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation
por: Huang, Haipeng, et al.
Publicado: (2022)

The effect of human chorionic gonadotrophin contained in human menopausal gonadotropin on the clinical outcomes during progestin-primed ovarian stimulation
por: Zhu, Xiuxian, et al.
Publicado: (2017)

Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations
por: Zhou, Ruiqiong, et al.
Publicado: (2023)

Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis
por: Shen, Yan-Wei, et al.
Publicado: (2015)

Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer
por: Lenhard, Miriam, et al.
Publicado: (2012)

Ovarian response after random-start controlled ovarian stimulation to cryopreserve oocytes in cancer patients
por: Campos, Ana Paula CB, et al.
Publicado: (2018)

The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer
por: Zhang, Xiao-Jin, et al.
Publicado: (2015)

Ovarian Follicular Growth through Intermittent Vaginal Gonadotropin Administration in Diminished Ovarian Reserve Women
por: Hsu, Chao-Chin, et al.
Publicado: (2022)

Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment
por: Gui, Ting, et al.
Publicado: (2015)

Management of Women With an Unexpected Low Ovarian Response to Gonadotropin
por: Conforti, Alessandro, et al.
Publicado: (2019)

Chorionic gonadotropin: Ovarian hyperstimulation syndrome: case report
Publicado: (2021)

Fertility outcomes in women after controlled ovarian stimulation with gonadotropin releasing hormone agonist long protocol: fresh versus frozen embryo transfer
por: Ding, Xiaoyan, et al.
Publicado: (2021)

Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol
por: Rabati, Behnaz Khani, et al.
Publicado: (2012)

Diazinon Interrupts Ovarian Steroidogenic Acute Regulatory (StAR) Gene Transcription in Gonadotropin-Stimulated Rat Model
por: Siavashpour, Asma, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rldv8fpvtkkpadlsjfb6ca8a5v